Related Experiment Video
Updated: Aug 14, 2026
06:36
Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve
Published on: September 26, 2018
Endocrinopathic Laminitis
1Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, 382 West Street Road, Kennett Square, PA 19348, USA.
The Veterinary Clinics of North America. Equine Practice
|August 12, 2026
Summary
Persistent hyperinsulinemia causes endocrinopathic laminitis. Early diagnosis via metabolic and radiographic screening, alongside insulin control through management and medication, is crucial for prevention and treatment.
Area of Science:
- Equine Medicine
- Veterinary Endocrinology
Background:
- Endocrinopathic laminitis stems from persistent hyperinsulinemia.
- This condition often presents subclinically, complicating early detection.
Purpose of the Study:
- To highlight the importance of insulin control in endocrinopathic laminitis.
- To emphasize the necessity of early diagnostic screening for subclinical cases.
Main Methods:
- Metabolic screening to assess risk factors.
- Radiographic screening to identify subclinical laminitic changes.
- Implementation of management and medication strategies for insulin control.
Main Results:
- Persistent hyperinsulinemia is identified as the primary cause.
- Subclinical laminitic changes can be detected through specialized screening.
- Integrated management and medication effectively control insulin levels.
Conclusions:
- Insulin control is paramount for preventing and treating endocrinopathic laminitis.
- Early detection via metabolic and radiographic screening is vital for subclinical cases.
- A combination of management changes and medication offers an effective therapeutic approach.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...